An oral ratiometric NIR-II fluorescent probe for reliable monitoring of gastrointestinal diseases in vivo.

Abstract

Early monitoring of gastrointestinal diseases via orally delivered NIR-II ratiometric fluorescent probes represents a promising noninvasive diagnostic modality, but is challenging due to the limitation of harsh digestive environment. Here, we report a single-component NIR-II ratiometric molecular nanoprobe (LC-1250 NP) to monitor gastrointestinal disease with high specificity to its biomarker H₂O₂ via oral administration. LC-1250 NP displays stable fluorescence in the channel of 1250 long-pass (F_1250LP) before and after the gastrointestinal disease detection as the reference, while it presents significantly enhanced fluorescence signal in the response channel of 1150 nm short-pass (F_1150SP) in diseased gastrointestinal environment due to the intramolecular cyclization of LC-1250 molecules activated by H₂O₂. The fluorescence ratio (F_1150SP/F_1250LP) increases linearly with the concentration of H₂O₂ with a low detection limit of 20 nM. Therefore, when delivered orally, LC-1250 NP can accurately map the diseased areas and surmount the false-positive interference from biological heterogeneity by NIR-II ratiometric fluorescence imaging, providing sensitive and reliable evaluation for the progress of gastroenteritis.